ZyVersa Therapeutics Inc. (ZVSA) Live Share Price, Invest From India

ZyVersa Therapeutics Inc. Stock Performance

as on May 16, 2026 at 6:02 am IST

Day's High
$0.18
Day's Price Range
$0.21
$0.18
16.67%
Upside
52 Week's Low
52 Week's High
$0.13
52-Week Price Range
$1.67
$0.18
30.17%
Downside
827.78%
Upside

ZyVersa Therapeutics Inc. share price movements today

Previous Close: $0.20
Open: $0.20
Volume: 112.2K
Day's Low - High: $0.18 - $0.21
52 Week Low - High: $0.13 - $1.67

ZyVersa Therapeutics Inc. Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

ZyVersa Therapeutics Inc. Stock Fundamentals & Key Indicators

Check ZyVersa Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.6M

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-6.8M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-112.65%

ZyVersa Therapeutics Inc. stock Key Stats

Compare market cap, revenue, PE, and other key metrics of ZyVersa Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
ZyVersa Therapeutics Inc.	BUY	$1.6M	NA	NA	0.00%

Analyst Recommendation on ZyVersa Therapeutics Inc. Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for ZyVersa Therapeutics Inc.. Average target price of $20

ZyVersa Therapeutics Inc. Share Price Target

Get share price movements and forecasts by analysts on ZyVersa Therapeutics Inc..

What analysts predicted

99.1%UPSIDE

Target Price

$20

Current Price

$0.18

Analyzed by

8 Analysts

Target

$20.00

ZyVersa Therapeutics Inc. target price $20, a slight upside of 99.1% compared to current price of $0.18. According to 8 analysts rating.

ZyVersa Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	0	0	-	-	0	-	-	-	-
Gross Profit	0	0	0	0	0	-	-	-	-
Operating Income	-1	-2	-2	-2	-1	-2,144	-2,044	-2	4,183
EBITDA	-95	-2	-2	-2	-1	-2	-2	-20	0
Interest Expense	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	-	-	-	-	-
Income Before Tax	-13	-2	-2	-2	-1	-2,256	-2,211	-20	4,463
Income Tax Expense	0	0	0	-	0	-	-	0	-
Net Income	-13	-2	-2	-2	-1	-2	-2	-19	0
Net Profit Margin	-85503.21%	-18120.11%	0.00%	0.00%	-5451.72%	0.00%	0.00%	0.00%	0.00%

ZyVersa Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	-
Operating Income	-11	-7	-13	-14	-9,136	-6
EBITDA	-12	-7	-14	-107	-9,136	-25
Interest Expense	0	0	0	0	0	0
Depreciation	0	0	0	0	0	-
Income Before Tax	-12	-8	-14	-107	-9,420	-25
Income Tax Expense	0	0	0	-9	-6	0
Net Income	-12	-8	-14	-98	-9,413	-24,952
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

ZyVersa Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-2	-2	-2	-1	-2	-2,211	-19,805	1,576	-1,793
Operating Cash Flow	-3	-1	0	-1	-1,772	-1,521	-1,406	-413	-799
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	2	-	0	2	1,852	-17	1,862	-12	1,000
Change in Cash	-1	-1	0	1	80	-1,539	455	-426	200

ZyVersa Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-8	-14	-98	-9	-24,952
Operating Cash Flow	-5	-4	-8	-7	-5,114
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	5	1	5	5	3,685
Change in Cash	0	5	-2	-1	-1,429

About ZyVersa Therapeutics Inc.

ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. It develops drug development platforms, including Cholesterol Efflux Mediator VAR 200, an injectable drug, which is in Phase 2a clinical trial for the treatment of renal indications, such as focal segmental glomerulosclerosis, alport syndrome, and diabetic kidney diseases; and Inflammasome ASC Inhibitor IC 100 a humanized monoclonal antibody inflammasome ASC inhibitor in preclinical development for the treatment of numerous inflammatory diseases, with cardiometabolic conditions associated with obesity as the lead. The company has a license agreement with L&F Research LLC, and InflamaCORE, LLC. ZyVersa Therapeutics, Inc. was founded in 2014 and is based in Weston, Florida.

Organisation	ZyVersa Therapeutics Inc.
Headquarters	2200 N. Commerce Parkway, Weston, FL, United States, 33326
Industry	Biotechnology
CEO	Mr. Stephen C. Glover
E-voting on shares	Click here to vote

Key Management of ZyVersa Therapeutics Inc.

Name	Title
Mr. Stephen C. Glover	Co-Founder, Chairman, CEO & President
Mr. Peter Wolfe	CFO & Secretary
Ms. Karen A. Cashmere	Chief Commercial Officer

FAQs

What is ZyVersa Therapeutics Inc. share price today?

ZyVersa Therapeutics Inc. share price today is $0.18 as on May 16, 2026 at 12:32 am IST at the close of the market. ZyVersa Therapeutics Inc. share today touched a day high of $0.21 and a low of $0.18.

What is the 52 week high and 52 week low for ZyVersa Therapeutics Inc. share?

ZyVersa Therapeutics Inc. share touched a 52 week high of $1.67 on July 8, 2025 and a 52 week low of $0.13 on January 5, 2026. ZyVersa Therapeutics Inc. stock price today i.e. May 16, 2026 at 12:32 am IST is closed at $0.18,which is 89.22% down from its 52 week high and 43.20% up from its 52 week low.

What is ZyVersa Therapeutics Inc.'s market capitalisation today?

ZyVersa Therapeutics Inc. market capitalisation is $0.00T as on May 16, 2026 at 12:32 am IST.

How to invest in ZyVersa Therapeutics Inc. Stock (ZVSA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for ZyVersa Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in ZyVersa Therapeutics Inc. Shares that will get you 8.3333 shares as per ZyVersa Therapeutics Inc. share price of $0.18 per share as on May 16, 2026 at 12:32 am IST.

What is the minimum amount required to buy ZyVersa Therapeutics Inc. Stock (ZVSA) from India?

Indian investors can start investing in ZyVersa Therapeutics Inc. (ZVSA) shares with as little as ₹95.955 or $1 (as of May 16, 2026 at 6:52 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹959.55 in ZyVersa Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on May 16, 2026 at 6:52 pm IST). Based on ZyVersa Therapeutics Inc. share’s latest price of $0.18 as on May 16, 2026 at 12:32 am IST, you will get 55.5556 shares of ZyVersa Therapeutics Inc.. Learn more about fractional shares .